A B S T R A C T Genes in the mnajor histocompatibility complex of mice and guinea pigs control immunologic responslveness to insulins from other animal species. In order to determine if similar genetic control exists in man, we have examined lymphocyte proliferation responses to components of therapeutic insulins by employing lymphocytes from diabetic patients that receive insulin.
INTRODUCTION
The immune response to protein antigens in experimental animals is controlled by genetic loci that are associated with the major histocompatibility complex (1) . These studies have largely been performed in inbred strains of mice or guinea pigs, where it has been clearly demonstrated that immune response (Ir)' genes map within the major histocompatibility complex (MHC) of the respective species. Insulins are one of a number of immunogens that have been used to map Ir genes. Using a variety of insulin analogues, MHC 'Abbreviations used in this paper: C-peptide, connecting peptide; Ir genes, immune response genes; JOD, juvenile onset diabetes; MHC, major histocompatibility complex. genes in both mice (2, 3) and guinea pigs (4, 5) have been demonstrated to control the immune response to restricted differences in amino acid composition of the A and B chains of the insulin molecule. Similarly, some mice have been shown to develop an immune response to proinsulin, but not to the insulin itself (6) .
In light of the probability that immune response genes also operate in man (7, 8) , we undertook a study to examine the possibility that insulin-receiving diabetic patients had restricted lymphocyte proliferative response to components present in therapeutic insulins. These included beef and pork insulin, beef and pork proinsulin, and protamine, which is an agent added to retard the absorption of insulin. This study was predicated on the knowledge that restricted immune responses are observed in mice and guinea pigs that are actively immunized with the insulins used for replacement therapy in man, and we reasoned that similar genetic control of these insulins should be present in man.
The results reported herein demonstrate that lymphocytes from individuals that receive insulin have restricted in vitro lymphocyte proliferative responses to beef and pork insulins, the connecting peptide (Cpeptide) of these insulins, and protamine. The association of these responses with increased and/or decreased HLA alloantigen frequencies suggests MHClinked genetic influence on the immune response of humans to these antigens.
METHODS
Patient population. A total of 137 patients were included in this study. 29 Each of the patients was tested on two separate occasions with these antigens. No significant differences in ratios of response or A cpm were seen in the lymphocyte stimulation studies that were performed on these two occasions. Ratios of response were calculated using base-line [3H]thymidine incorporation (mean counts per minute) in the triplicate cultures (no antigen) and the mean counts per minute in triplicate cultures at the antigen concentration that gave maximal stimulation. A positive response was determined as follows. The mean of the ratio of the responses <2 was determined as well as the standard deviation from this mean. These individuals were considered nonresponders. Any response 2 SD > mean of the nonresponders was considered a positive response.
The duration of insulin administration was considered as having a potential effect on in vitro lymphocyte stimulation by the insulins. This factor was considered in relationship to the level of stimulation and to the category of response and nonresponse. No correlation was found.
HLA typing. HLA-A, B, C, and DR typing was performed on the peripheral blood lymphocytes from these patients by the microcytoxicity test described by Amos et al. (11) . B lymphocytes for HLA-DR typing were isolated from the lymphocyte preparations using the Fab technique described by Mann et al. (12) . Antisera that were used for detecting the HLA-DR determinants had For 30 individuals of this population, there was a selective recognition of beef insulin (Fig. 2) . This was evident by a response to beef but not to pork insulin (12 patients) or by a response to beef insulin which was significantly greater than that to pork (18 patients). The ratio of response to beef was much greater than that to pork insulin (Figs. 1 and 3) . The immune response of these individuals appears to be recognizing the A chain amino acid differences of the beef insulin molecule.
The C-peptide of proinsulin is known in animal studies to represent a separate domain of immune recognition, and this was reflected in the human proliferation studies as well. In 35 patients, a proliferative response was present for beef proinsulin but not for beef insulin, or the response was significantly greater to beef proinsulin than to beef insulin (Fig. 4) ; in 48 patients, a similar pattern was observed with pork proinsulin and pork insulin ( FIGURE 6 ulation. Ratios of lymphocyte response to protamine stimthe nonresponder population. This difference was significant at the level of P < 0.005. A positive proliferative response to the C-peptide domain of beef proinsulin was associated with several different HLA alloantigens. The most dramatic increase in antigen frequency was for HLA-CW5 which occurred in only 9% of nonresponders and 43% of responders. Significant increases were also observed in HLA-BW4, CW2, DR2, and DR5. The increases in CW2 and DR2 were most striking in the Black population, but the numbers were too small to be certain of the biological significance of the racial difference in response.
Although the C-peptide of beef and pork proinsulin differ from each other to almost the same extent that they differ from human C-peptide, the only HLA alloantigen positively associated with a pork proinsulin response was DR2, an antigen also associated with a beef proinsulin response. Again, this association was most dramatic in the Black population. In addition, two antigens, HLA-BW4 and DR3, were negatively associated with a pork proinsulin response.
HLA-A3 was decreased in frequency in the popu- There are several reports that show an association of HLA alloantigens with antibody production to insulin in diabetic patients. Schernthaner and Mayr (23) as well as Bertrams and Grunklee (24) have studied patients with juvenile onset diabetes (JOD) and demonstrated that the development of antibodies to insulin was increased in frequency in individuals who were HLA-DR4 and decreased in frequency in individuals who were HLA-DR3 (10) . These studies employed bovine insulin to measure insulin antibodies. Since lymphocyte proliferation in response to antigenic stimulation may represent the response of helper T cells, these studies complement our studies in that an increased HLA-DR4 frequency was observed in those individuals whose lymphocytes responded to beef insulin. When considered together, these studies suggest that the human immune system is capable of recognizing the two amino acid differences in beef and human insulin in the A chain of the insulin molecule and that there are Ir genes that are closely associated with the gene controlling HLA-DR expression. This argument is strengthened by similar observations in the above two groups selected on the basis of onset of diabetes, JOD, and the other group (this study) selected on basis of insulin administration which includes both JOD and mature onset diabetes.
We also observed a positive association of HLA-DR3 with the in vitro lymphocyte proliferative responses to beef and pork insulin. These insulins have in common the carboxy-terminal amino acid which differs from the amino acid at that position in human insulin. No Contrasting the HLA antigen frequencies in the beef proinsulin and pork proinsulin responders with the frequencies of HLA antigens in the individuals who responded to beef and pork insulin adds further evidence for selective Ir genes to these therapeutic insulin components. DR5 was increased in frequency in the beef proinsulin responders and decreased in frequency in individuals whose lymphocytes responded to the beef insulin. HLA-DR3 was decreased in frequency in those individuals who responded to pork proinsulin, but was increased in frequency in individuals who responded to beef and pork proinsulins. These results also point out the complexity of establishing evidence for Ir genes in man. By its very nature, the proinsulin molecule possesses the beef or pork insulin molecule. Although some regions of the molecule are probably covered by the C-peptide in the three-dimensional folding of the molecule, there were individuals who responded to both the beef or pork insulin and to the respective proinsulins containing beef or pork insulin backbones, but where the response to the latter was greater than that to the former. For the purpose of analysis, these individuals have been included in the responder population to both beef and/or pork insulin and to the proinsulins of the respective species. The HLA frequencies that differentiate the insulin-proinsulin responders might be considerably more clear cut if the problem were not confounded by multiple determinants of the antigen (i.e., beef; beef proinsulin) and the complexity of the Ir genes in the outbred human.
A strong suggestion that the lymphoproliferative response to the histone protamine is under control of the MHC is a new observation. These responses were observed not only in some diabetics "immunized" with protamine-containing insulin, but also in a segment of the normal population. The same HLA association (CW5 and HLA-DR7) were observed in the nondiabetic protamine responders (unpublished observation). Whether or not this proliferative response represents a primary response in the "nonimmunized," nondiabetic individuals remains to be determined. Certainly, the possibility exists that protamine may serve as an adjuvant in the presentation of the insulin molecule, and in fact augment the immune response to the insulin in those individuals with Ir genes for protamine. This hypothesis would predict that admin-istration of the synthetic human insulins with protamine will result in an immune response (possibly antibody) to the insulin in selected diabetic patients.
Positive responses to each of the antigens used in this study showed an association with one or another of the HLA-DR antigens. This is the association that one might expect if the human Ir genes map with that portion of the MHC that controls the expression of "Ia-like" antigens. Antigens controlled by loci other than DR were also elevated in frequency in the responder populations to beef proinsulin and protamine. This could be due to a multiple gene effect on response or to linkage disequilibrium of the antigens involved. This question could not be addressed in that the number of patients evaluated was too small to calculate haplotype frequencies. In addition, the patient population may have altered linkage groups because of their disease. The HLA-A3 frequency in the Caucasian and Black responder/nonresponder populations to protamine may be an example of linkage disequilibrium in different racial groups where it was observed that this antigen has significant association in one racial group (nonresponders) and no association in another.
In general, the frequency of an HLA antigen in one race in the population that responded to a particular insulin or protamine was reflected in a similar increase or decrease in the other race. These results tend to substantiate the hypothesis of an MHC-associated gene(s) that regulated or controlled the lymphoproliferative response to therapeutic insulins in that HLA antigen association was consistent in the two races where the frequencies of the antigen differ.
The strong association of HLA-DR4 with in vitro lymphocyte proliferative response to beef insulin and the previously reported association of this HLA antigen with antibody production to beef insulin has potential therapeutic implications. The clinician may elect to use insulins other than beef-derived insulin in diabetics who type for the HLA-DR4 antigen, and thus avoid the complications of insulin resistance (due to antibody to insulin) and potential adverse allergic reactions.
The results of this study substantiate an association of genes in the MHC with an in vitro parameter of the immune response. Since bovine and porcine insulins have relatively restricted differences from human insulin, a potential model for further dissection of Ir genes in man is established.
